Their report discusses the tensions between the TRIPS Agreement and International Human Rights Law as they apply to pharmaceuticals, and how those tensions have played out in the COVID-19 pandemic. They identify some opportunities for systemic integration, and ask questions about the unsolved issues around states’ extraterritorial human rights obligations and pharmaceutical companies’ responsibilities.

Their report was one in a series of reports, commissioned under the theme ‘Global Health Law Disrupted: Covid-19 and the Climate Crisis’. 

Katrina Perehudoff would like to thank Prof. Em. Willem van Genugten, Prof. Brigit Toebes and her co-authors.